Cargando…

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

Currently, a standard third-line therapy for Helicobacter pylori (H. pylori) eradication remains to be established. Quinolones show good oral absorption, no major side effects, and marked activity against H. pylori. Several authors have studied quinolone-based third-line therapy and reported encoura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishizawa, Toshihiro, Suzuki, Hidekazu, Hibi, Toshifumi
Formato:	Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654467/ https://www.ncbi.nlm.nih.gov/pubmed/19308265 http://dx.doi.org/10.3164/jcbn.08-220R

Ejemplares similares

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy
por: Hirata, Kenro, et al.
Publicado: (2013)

H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2010)

Current Status of the Third-Line Helicobacter pylori Eradication
por: Choi, Jae Ho, et al.
Publicado: (2018)

Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones
por: Gisbert, Javier P.
Publicado: (2020)

Update on quinolone-containing rescue therapies for Helicobacter pylori infection
por: Mori, Hideki, et al.
Publicado: (2020)

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

Helicobacter pylori: present status and future prospects in Japan
por: Suzuki, Hidekazu, et al.
Publicado: (2007)

Helicobacter pylori eradication improved the Kyoto classification score on endoscopy
por: Toyoshima, Osamu, et al.
Publicado: (2020)

What Is the Difference Between Helicobacter pylori-Associated Dyspepsia and Functional Dyspepsia?
por: Suzuki, Hidekazu, et al.
Publicado: (2011)

Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2017)

Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing
por: Nishizawa, Toshihiro, et al.
Publicado: (2014)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)

Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori
por: Nishizawa, Toshihiro, et al.
Publicado: (2016)

Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis
por: Suzuki, Hidekazu, et al.
Publicado: (2009)

Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients
por: Mori, Hideki, et al.
Publicado: (2019)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Helicobacter pylori Eradication Therapy: Current Availabilities
por: Gasparetto, M., et al.
Publicado: (2012)

Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
por: Saito, Yoshimasa, et al.
Publicado: (2019)

The impacts of probiotics in eradication therapy of Helicobacter pylori
por: Bai, Xiaofen, et al.
Publicado: (2022)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
por: De Francesco, Vincenzo, et al.
Publicado: (2017)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication
por: Saito, Yoshimasa, et al.
Publicado: (2012)

Role of Tegoprazan in Helicobacter pylori Eradication Therapy
por: Lee, Jin
Publicado: (2022)

Helicobacter pylori eradication therapy: A review of current trends
por: Olokoba, A. B., et al.
Publicado: (2013)

Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication
por: Kusunoki, Maho, et al.
Publicado: (2019)

Roles of oxidative stress in stomach disorders
por: Suzuki, Hidekazu, et al.
Publicado: (2012)

World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
por: Suzuki, Hidekazu, et al.
Publicado: (2017)

The role of acid inhibition in Helicobacter pylori eradication
por: Scott, David R., et al.
Publicado: (2016)

Personalized Approach in Eradication of Helicobacter pylori Infection
por: Mestrovic, Antonio, et al.
Publicado: (2022)

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
por: Navarro-Jarabo, José M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_l33rq755h25faft4jse085tusv